Hyaluronic acid derivative with urethane linkage

(19)

(11)

EP 1 538 166 B8

(12)	CORRECTED EUROPEAN PATENT SPECIFICATION
	Note: Bibliography reflects the latest situation

(15)	Correction information:
	Corrected version no 1 (W1 B1)

(48)	Corrigendum issued on:
	08.04.2009 Bulletin 2009/15

(45)	Mention of the grant of the patent:
	18.02.2009 Bulletin 2009/08

(21)	Application number: 04256686.9

(22)	Date of filing: 29.10.2004

(51)

International Patent Classification (IPC):

C08B 37/08^(2006.01)
A61K 47/48^(2006.01)

A61K 47/36^(2006.01)

(54)	Hyaluronic acid derivative with urethane linkage Hyaluronsäurederivat mit einer Urethanbindung Dérivé de l'acide hyaluronique avec un groupement uréthane

(84)	Designated Contracting States:
	AT BE BG CH CY CZ DE DK EE ES FI FR GR HU IE IT LI LU MC NL PL PT RO SE SI SK TR

(30)

Priority:

04.12.2003 GB 0328168

(43)	Date of publication of application:
	08.06.2005 Bulletin 2005/23

(73)	Proprietor: INDUSTRIAL TECHNOLOGY RESEARCH INSTITUTE
	Chutung, Hsinchu (TW)

(72)	Inventors:
	Chen, Jui-Hsiang Hsinchu Taiwan (CN) Tsai, Bin-Hong Kaohsiung Taiwan (CN) Chang, Hsuen-Tseng Sinsing District Kaohsiung City Taiwan (CN) Chen, Muh-Lan Hsinchu City Taiwan (CN) Chen, Yu-Hua South District Taichung City Taiwan (CN) Jan, Shu-Hua Yungjing Shiang Changhua Taiwan (CN) Liu, Mei-Jung Miaoli Taiwan (CN)

(74)	Representative: Jacob, Reuben Ellis et al
	R G C Jenkins & Co. 26 Caxton Street London SW1H 0RJ London SW1H 0RJ (GB)

(56)

References cited: :

WO-A-02/098923
US-A- 5 705 270

US-A- 5 510 418

Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).